Overview
No overview information available.
Indication
用于缓解骨关节炎以及急性闭合性软组织损伤后所致的肿胀、疼痛症状。
Associated Conditions
- Pain caused by Rheumatism
- Pain caused by Soft Tissue Injury
- Arthritic pain
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2022/03/28 | Phase 3 | Completed | Shijiazhuang Yiling Pharmaceutical Co. Ltd | ||
2021/10/20 | Phase 1 | UNKNOWN | Beijing Tongren Hospital | ||
2020/08/25 | Phase 3 | Completed | Shijiazhuang Yiling Pharmaceutical Co. Ltd | ||
2019/03/13 | Phase 2 | Completed | Shijiazhuang Yiling Pharmaceutical Co. Ltd | ||
2018/08/06 | Phase 1 | Completed | Shijiazhuang Yiling Pharmaceutical Co. Ltd | ||
2017/08/01 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Felbinac Gel | 国药准字H20173088 | 化学药品 | 凝胶剂 | 12/15/2021 | |
| Felbinac Gel | 国药准字H20080491 | 化学药品 | 凝胶剂 | 3/15/2023 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.